Literature DB >> 386029

Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations.

R C Turner, R R Holman, D Matthews, T D Hockaday, J Peto.   

Abstract

The liver and beta cells function in a negative feedback loop, which appears to have a predominant role in regulating both the basal plasma glucose and insulin concentrations. The degree of basal hyperglycemia in diabetes probably provides a bioassay of both the effect of a reduction in insulin secretory capacity and the degree of insulin resistance. A mathematic model of the interaction of insulin deficiency and insulin resistance has been constructed, based on the known response characteristics of the beta cells to glucose, and of plasma glucose and insulin control of hepatic and peripherpal glucose flux. The degree to which beta cell deficiency increases basal plasma glucose reflects the hyperbolic shape of the normal insulin secretory response to different glucose concentrations. The height of basal plasma insulin is a function of the degree of insulin resistance. From the basal plasma insulin and glucose concentrations, the model provides an estimate of the degree to which both beta cell deficiency and insulin resistance contribute to diabetes. The predictions arising from the model are in accord with experimental data in man and in animals. In normal-weight diabetics who do not have increased insulin resistance, the model predicts that more than 85% of beta cell function has to be lost for the basal plasma glucose to rise to 6 mmol/liter, but a further 5%--10% loss increases the basal plasma glucose to over 10 mmol/liter. In a third of a consecutive series of 65 newly presenting, uncomplicated diabetics, both normal weight and obese, the analysis from the model suggested that insulin resistance, rather than beta cell deficit, was the predominant feature.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 386029     DOI: 10.1016/0026-0495(79)90146-x

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  84 in total

1.  --to: Hales CN, Barker DJP (1992) Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 35:595-601.

Authors:  T D R Hockaday; C S Yajnik
Journal:  Diabetologia       Date:  2003-02-12       Impact factor: 10.122

2.  Curcumin attenuates Nrf2 signaling defect, oxidative stress in muscle and glucose intolerance in high fat diet-fed mice.

Authors:  Hui-Jun He; Guo-Yu Wang; Yuan Gao; Wen-Hua Ling; Zhi-Wen Yu; Tian-Ru Jin
Journal:  World J Diabetes       Date:  2012-05-15

3.  The hyperbolic law--a 25-year perspective.

Authors:  M Stumvoll; P A Tataranni; C Bogardus
Journal:  Diabetologia       Date:  2005-02       Impact factor: 10.122

4.  Re: The hyperbolic law--a 25-year perspective.

Authors:  T D R Hockaday
Journal:  Diabetologia       Date:  2005-02-03       Impact factor: 10.122

5.  Exercise counteracts the effects of short-term overfeeding and reduced physical activity independent of energy imbalance in healthy young men.

Authors:  Jean-Philippe Walhin; Judith D Richardson; James A Betts; Dylan Thompson
Journal:  J Physiol       Date:  2013-10-28       Impact factor: 5.182

6.  Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta-cell function in man.

Authors:  J P Hosker; D R Matthews; A S Rudenski; M A Burnett; P Darling; E G Bown; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

7.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

8.  Fasting plasma magnesium concentrations and glucose disposal in diabetes.

Authors:  C S Yajnik; R F Smith; T D Hockaday; N I Ward
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-07

Review 9.  Pharmacokinetic/pharmacodynamic modelling in diabetes mellitus.

Authors:  Cornelia B Landersdorfer; William J Jusko
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

10.  Clinical and biochemical manifestations of syndrome X in obese children.

Authors:  Efimia Papadopoulou-Alataki; Kiriaki Papadopoulou-Legbelou; Loukas Doukas; Kiparissia Karatzidou; Aikaterini Pavlitou-Tsiontsi; Emmanouil Pagkalos
Journal:  Eur J Pediatr       Date:  2004-10       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.